Interest in this protein has focused on the ability of BCAR3 (Breast Cancer Anti-Estrogen Resistance 3), the human homolog of AND-34, to induce anti-estrogen resistance in breast cancer in concert with p130Cas (BCAR1) [5-8]. This evidence concerns the gene BCAR1 and breast carcinoma.